Nature Mental Health, Published online: 06 July 2026; doi:10.1038/s44220-026-00671-z
In this precision trial, Zhukovsky et al. developed algorithms to predict sertraline or bupropion response, assigning independent, medication-free patients with major depressive disorder to one drug or the other on the basis of biobehavioral precision markers validated in a prospective trial.